Join us for our online symposium at the 31st ECCMID congress and discover the latest on gold-standard molecular testing technology and surveillance options for understanding the evolution of viral pathogens such as SARS-CoV-2.
If you are planning to attend ECCMID 2021, why not join us on 09 July, 2021 to find out more about how recent emerging SARS-CoV-2 variants have accumulated significantly more mutations in short periods of time, causing concern around the globe. Scientists predict that these mutant lineages of the SARS-CoV-2 strain will not be the only concerning variants that emerge, caused by continued uncontrolled transmission of SARS-CoV-2 and selective pressures.
In our interactive symposium, scientific experts will share their latest results on SARS-CoV-2 detection, mutation verification and sequencing to help the world to rapidly gain insights regarding SARS-CoV-2 spread, mutation rate and infection risk.
Viruses mutate and SARS-CoV-2 is no exception
Emerging mutation surveillance and confirmation
Date: Friday 09 July, 2021, 13.15– 15.15 CEST
Thermo Fisher Scientific solutions for SARS-CoV-2 isolation, detection, mutation conformation and surveillance – discover a world of innovation at your fingertips
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivalled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.